106P Palbociclib (PAL) in male patients (pts) with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC): Pt characteristics and treatment (Tx) patterns from the POLARIS study
Title:
106P Palbociclib (PAL) in male patients (pts) with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC): Pt characteristics and treatment (Tx) patterns from the POLARIS study
Author:
Blum, J.L. Dicristo, C. Gordon, D. Karuturi, M. Oubre, D. Jepsen, E. Cuevas, J. Lakhanpal, S. Zhang, Z. Drucker, M. Wang, Y. Tripathy, D.